The mechanism of Bodian's silver staining: effect of copper ion on silver impregnation. 1996

H Kondo, and K Ikeda, and N Miyazaki
Department of Neuropathology, Tokyo Institute of Psychiatry, Japan.

We studied the effect of the duration (0.5-48 h) of silver impregnation on the intensity of Bodian's silver staining using formalin-fixed, paraffin-embedded sections of a human brain. The silver ion (Ag+) and copper ion (Cu2+) in the silver protein solution were quantified simultaneously for treatments of various durations. Both the intensity of staining and the quantities of Ag+ and Cu2+ were greatly affected by the duration of silver impregnation. While the quantity of Ag+ considerably decreased during the first 4 h of impregnation, that of Cu2+ greatly increased. Only small changes were observed in both ions after 12 h. Neurofibrils or axons, and neurofibrillary tangles (NFTs) were clearly stained after 12-24 and 16-48 h of impregnation, respectively. Strong staining of these components was not observed for other durations of treatment. The amount of metallic copper in silver impregnation also affected both the intensity of staining and the quantities of Ag+ and Cu2+ in the silver protein solution. Ag+ and Cu2+ were also present in the gold trichloride acid solution in which the section was toned. These findings suggest that both Cu2+ derived from metallic copper and silver protein are deposited on sections during silver impregnation, that the amount of Cu2+ may determine the amount of silver protein deposited on the section, and that the reduced (metallic) form of silver and copper on the section may participate in gold toning. Thus, to achieve strong staining of a desired component, it is important to examine the conditions of silver impregnation (i.e. duration and amount of metallic copper). For strong staining of neurofibrils, axons and NFTs, optimal results are obtained by the addition of 5 g of metallic copper foil to 100 ml of 1% silver protein solution, and by 16-24 h of impregnation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D016622 Silver Staining The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens. Silver Nitrate Staining,Nitrate Staining, Silver,Staining, Silver,Staining, Silver Nitrate

Related Publications

H Kondo, and K Ikeda, and N Miyazaki
August 1971, Rinsho byori. The Japanese journal of clinical pathology,
H Kondo, and K Ikeda, and N Miyazaki
January 1955, Virchows Archiv fur pathologische Anatomie und Physiologie und fur klinische Medizin,
H Kondo, and K Ikeda, and N Miyazaki
July 1953, Journal of anatomy,
H Kondo, and K Ikeda, and N Miyazaki
November 1957, Stain technology,
H Kondo, and K Ikeda, and N Miyazaki
September 1965, Stain technology,
H Kondo, and K Ikeda, and N Miyazaki
July 1953, Journal of anatomy,
H Kondo, and K Ikeda, and N Miyazaki
January 1962, Acta anatomica,
H Kondo, and K Ikeda, and N Miyazaki
September 1951, American journal of clinical pathology,
H Kondo, and K Ikeda, and N Miyazaki
January 2008, The open dentistry journal,
Copied contents to your clipboard!